India scraps requirements of J&J to conduct COVID-19 vaccine trials in India
Pfizer, BioNTech seek authorisation for third dose of Covid-19 vaccine
While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement
Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India as per reports from "The Economic Times"
While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the report.